PBS process improvements webinar information forum

27 March 2019 - The Department of Health will be hosting a webinar on 5 April 2019 to provide industry, ...

Read more →

Pharmaceutical Benefits Scheme process improvements webinar information forum

21 February 2019 - The Department of Health will be hosting a webinar to provide industry, consumers and clinicians with ...

Read more →

PHARMAC to review its practices following criticism of breast cancer drug funding

13 February 2019 - The government's drug-buying agency has announced it has begun an internal review following a petition and ...

Read more →

NHS England in legal battle with American firm over medicine procurement

7 November 2018 - An American pharmaceutical company has launched a legal challenge against NHS England over a procurement process ...

Read more →

Digital technology could revolutionise drug reimbursement in Spain

8 October 2018 - Digital technology could play a major role in creating a system that reimburses medicines based on ...

Read more →

Revised process for ultra-orphan medicines

8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...

Read more →

New Ministerial discretion guidance for first new brand statutory price reductions

2 October 2018 - Guidance material on requesting Ministerial discretion for first new brand statutory price reductions is now available. ...

Read more →

Information forums - streamlining PBS medicines listing processes

18 September 2018 - The Department of Health in collaboration with Medicines Australia will be hosting information forums in both ...

Read more →

Changes to TGA/PBAC parallel processing arrangements for biosimilar medicines

18 September 2018 - Submissions requesting the listing of a new biosimilar medicine are no longer eligible to be submitted under ...

Read more →

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...

Read more →

Update on revised process for biosimilars

12 December 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the submission and ...

Read more →

FDA aims to expand early approval program for promising drugs

30 November 2017 - Scott Gottlieb speaks before House subcommittee on health. ...

Read more →

Revised process for filing CDR submissions and resubmissions

27 November 2017 - The CADTH Common Drug Review is aligning the process for secure file sharing with the pan-Canadian ...

Read more →

Revised procedure for the CADTH Common Drug Review resubmissions

13 November 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements ...

Read more →

FDA unveils a streamlined path for the authorisation of tumour profiling tests alongside its latest product action

15 November 2017 - The U.S. FDA today authorised Memorial Sloan Kettering Cancer Center’s IMPACT (Integrated Mutation Profiling of Actionable Cancer ...

Read more →